Graduated with distinction from the Faculty of Medicine of the Medical University of Poznań in 2001. PhD degree in medical sciences awarded in 2007. Assistant Professor at the Department of Haematology and Bone Marrow Transplantation of the Medical University of Poznań since 2002. A pioneer in the use of proteomics in exploring the biology and resistance mechanisms of multiple myeloma. Dominik Dytfeld has provided active contribution to multiple clinical projects investigating the efficacy of novel myeloma therapies.
His research is focused on optimal determination of prognostic factors and individualization of anticancer therapy. He has co-authored a number of textbook chapters and papers in internationally recognised medical journals, including Blood, British Journal of Haematology, Haematologica, and Leukemia&Lymphoma. He completed fellowships in the USA under the guidance of Andrzej Jakubowiak (University of Michigan and University of Chicago), and in Germany (Christian-Albrechts-Universität zu Kiel and Universität des Saarlandes).
Active member of the Polish Myeloma Group (PGSz). Co-founder and President of the Polish Myeloma Consortium (PMC). Highly recognised academic teacher appreciated by both students (“Amicus Studentium” award granted by the students of the Faculty of Medicine in 2011) and his fellow professionals ("Mentor" award by the Regional Medical Chamber).